The Scientific Research Team at Ratio Therapeutics spearheads the development of cutting-edge targeted radiotherapeutics for cancer treatment. Comprising specialists in chemistry, pharmacology, and biology, this team leverages innovative technologies to advance drug discovery and optimize early clinical phase development.